|

YCJ-01 Full Spectrum cannbis Extract Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Oils4Cure1

Indications

  • Tuberous Sclerosis Complex (TSC)1
  • Multiple Sclerosis1
  • Cancer1

Other1 trial

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.